Sudden attacks of sleepiness and hypersomnia constitute a rare set of symptoms that is characterized by unexpected and unstable periods of sleepiness during the day. The causes of this disorder are not yet fully understood, however, in some cases a deficiency of a molecule called hypocretin, which is produced by the brain, is observed. This condition is not fatal, but it can significantly limit the quality of life of those affected
Narcolepsy: Definition, symptoms, and neurological classification of the sleep disorder
Narcolepsy is a rare, chronic neurological disorder affecting sleep-wake regulation, characterized by sudden, irresistible episodes of daytime sleepiness that typically last no longer than ten minutes. The International Classification of Sleep Disorders (ICSD-3) delineates three distinct forms of this condition: **Type 1 narcolepsy** (associated with cataplexy—an abrupt, reversible, and transient loss of muscle tone triggered by hypocretin deficiency in the central nervous system), **Type 2 narcolepsy** (initially lacking cataplectic symptoms, though they may emerge as the disease progresses; the precise etiology remains unclear), and **secondary narcolepsy**, which arises due to pharmacological interventions or co-occurs with other medical conditions, such as brain tumors or head trauma. Estimated incidence rates for Type 1 narcolepsy stand at approximately 25 cases per 100,000 individuals, whereas Type 2 affects 25–34 per 100,000. The disorder most commonly debuts between the ages of 15 and 35, with a higher prevalence in males, though pediatric cases are also documented. While narcolepsy is not fatal, it significantly diminishes quality of life by impairing daily functioning—severely limiting or even precluding activities that demand sustained attention, such as operating motor vehicles or engaging in high-risk sports.
You have started reading a PRO article
You can preview the first chapter. To read the complete article and unlock all content, upgrade to a PRO account.